Abstract: The present invention relates to heteroalicyclic compounds represented by the general formula (I), or their isotopic forms, stereoisomers, or pharmaceutically acceptable salts thereof. The present invention also describes a method of making such compounds, pharmaceutical compositions comprising such compounds and their use for the treatment or prevention of central nervous system related disorders.
Claims attached.
| # | Name | Date |
|---|---|---|
| 1 | 202447050520-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [02-07-2024(online)].pdf | 2024-07-02 |
| 2 | 202447050520-STATEMENT OF UNDERTAKING (FORM 3) [02-07-2024(online)].pdf | 2024-07-02 |
| 3 | 202447050520-REQUEST FOR EXAMINATION (FORM-18) [02-07-2024(online)].pdf | 2024-07-02 |
| 4 | 202447050520-PRIORITY DOCUMENTS [02-07-2024(online)].pdf | 2024-07-02 |
| 5 | 202447050520-POWER OF AUTHORITY [02-07-2024(online)].pdf | 2024-07-02 |
| 6 | 202447050520-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [02-07-2024(online)].pdf | 2024-07-02 |
| 7 | 202447050520-FORM 18 [02-07-2024(online)].pdf | 2024-07-02 |
| 8 | 202447050520-FORM 1 [02-07-2024(online)].pdf | 2024-07-02 |
| 9 | 202447050520-FIGURE OF ABSTRACT [02-07-2024(online)].pdf | 2024-07-02 |
| 10 | 202447050520-DRAWINGS [02-07-2024(online)].pdf | 2024-07-02 |
| 11 | 202447050520-DECLARATION OF INVENTORSHIP (FORM 5) [02-07-2024(online)].pdf | 2024-07-02 |
| 12 | 202447050520-COMPLETE SPECIFICATION [02-07-2024(online)].pdf | 2024-07-02 |
| 13 | 202447050520-Proof of Right [25-07-2024(online)].pdf | 2024-07-25 |
| 14 | 202447050520-FORM 3 [15-11-2024(online)].pdf | 2024-11-15 |